What is it about?
This study analyzed passive surveillance data on COVID-19 vaccine adverse reactions in the United State which were retrieved from the Vaccine Adverse Event Reporting System database. Retrieved records on demographic information as well as the top 10 common vaccine adverse events were extracted and assessed from 200 of the most recently reported cases for the study analysis.
Featured Image
Photo by CDC on Unsplash
Why is it important?
In the United States, Pfizer-BioNTech, Moderna, and Janssen’s coronavirus disease 2019 (COVID-19) vaccines have been granted Emergency Use Authorization (EUA) with the Pfizer-BioNTech vaccine presently approved by the US Food and Drug Administration. Hence, there is a need to document adverse reactions from the vaccination.
Perspectives
Mild side effects were reported following vaccination with the EUA COVID-19 vaccines in the United States. Thus, continuous monitoring and reporting of all adverse events are recommended to ensure the safety of vaccination.
Dr Adekunle Sanyaolu
Read the Original
This page is a summary of: Reactogenicity to COVID-19 vaccination in the United States of America, Clinical and Experimental Vaccine Research, January 2022, Korean Vaccine Society (KAMJE),
DOI: 10.7774/cevr.2022.11.1.104.
You can read the full text:
Resources
Contributors
The following have contributed to this page
